GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 133 filers reported holding GENOMIC HEALTH INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $30,093,000 | +13.8% | 1,023,933 | +12.0% | 0.01% | +20.0% |
| Q3 2016 | $26,433,000 | +17.9% | 914,017 | +5.5% | 0.01% | 0.0% |
| Q2 2016 | $22,426,000 | +6.7% | 866,021 | +2.1% | 0.01% | 0.0% |
| Q1 2016 | $21,016,000 | -26.6% | 848,433 | +4.3% | 0.01% | -28.6% |
| Q4 2015 | $28,642,000 | +53.3% | 813,704 | -7.8% | 0.01% | +40.0% |
| Q3 2015 | $18,682,000 | -19.4% | 882,888 | +5.9% | 0.01% | -16.7% |
| Q2 2015 | $23,171,000 | -8.0% | 833,783 | +1.2% | 0.01% | 0.0% |
| Q1 2015 | $25,181,000 | -1.6% | 824,251 | +3.0% | 0.01% | 0.0% |
| Q4 2014 | $25,592,000 | +21.5% | 800,501 | +7.6% | 0.01% | 0.0% |
| Q3 2014 | $21,061,000 | +4.1% | 743,935 | +0.8% | 0.01% | 0.0% |
| Q2 2014 | $20,227,000 | -3.5% | 738,214 | -7.2% | 0.01% | 0.0% |
| Q1 2014 | $20,963,000 | -6.2% | 795,858 | +4.2% | 0.01% | -14.3% |
| Q4 2013 | $22,346,000 | -4.9% | 763,429 | -0.6% | 0.01% | -12.5% |
| Q3 2013 | $23,495,000 | +11.9% | 768,328 | +16.0% | 0.01% | 0.0% |
| Q2 2013 | $21,002,000 | – | 662,327 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RAMIUS ADVISORS LLC | 430,490 | $29,196,000 | 6.86% |
| Baker Brothers Advisors | 9,244,665 | $626,973,000 | 4.26% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 789,540 | $53,546,000 | 1.75% |
| HARVEST MANAGEMENT LLC | 18,500 | $1,255,000 | 1.75% |
| HAVENS ADVISORS LLC | 28,000 | $1,899,000 | 1.73% |
| Exane Asset Management | 30,000 | $2,034,600,000 | 1.56% |
| EMORY UNIVERSITY | 9,506 | $645,000 | 1.27% |
| IndexIQ Advisors LLC | 440,780 | $29,894,000 | 1.06% |
| ALPHASIMPLEX GROUP, LLC | 37,537 | $2,546,000 | 0.97% |
| Magnetar Financial LLC | 483,143 | $32,767,000 | 0.83% |